iHuman
13 hedge funds and large institutions have $32.8M invested in iHuman in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more funds holding
Funds holding: 10 → 13 (+3)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.73% less ownership
Funds ownership: 2.97% → 2.24% (-0.73%)
48% less capital invested
Capital invested by funds: $63.2M → $32.8M (-$30.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$2.25M |
| 2 |
BlackRock
New York
|
+$1.33M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
+$507K |
| 4 |
JP Morgan Chase
New York
|
+$316K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$220K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAEMF
Panview Asian Equity Master Fund
Central,
Hong Kong
|
-$7.84M |
| 2 |
SCH
Sylebra Capital (HK)
Hong Kong
|
-$7.16M |
| 3 |
TAMH
Taikang Asset Management (HK)
Hong Kong
|
-$2.7M |
| 4 |
Morgan Stanley
New York
|
-$2.36M |
| 5 |
Millennium Management
New York
|
-$300K |
IH Hedge Fund Activity: Q1 2021 in Review
13 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in iHuman (IH) for Q1 2021, worth a combined $32.8M — down 48% from $63.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new IH positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Credit Suisse, adding an estimated $2.25M. The largest seller was Panview Asian Equity Master Fund, exiting entirely with an estimated $7.84M sold.
- 13 institutional investors held iHuman (IH) as of Q1 2021, up from 10 in Q4 2020.
- Funds reported $32.8M of iHuman stock for Q1 2021, down 48% quarter-over-quarter.
- 6 funds opened new iHuman positions in Q1 2021 and 3 closed out, a net change of +3 holders.
- The largest iHuman buyer in Q1 2021 was Credit Suisse, an estimated $2.25M added.
- The largest iHuman seller in Q1 2021 was Panview Asian Equity Master Fund, an estimated $7.84M sold.
Based on aggregated 13F filings for Q1 2021.